Search results
Results from the WOW.Com Content Network
Rilpivirine and cabotegravir were approved for medical use in the European Union in December 2020, as two separate medications. [11] [12] In January 2021, the U.S. Food and Drug Administration (FDA) granted the approval of Cabenuva to ViiV Healthcare. [4] [8] The combination was approved for medical use in Australia in February 2021. [14] [15]
Cabotegravir in combination with rilpivirine is indicated for the treatment of human immunodeficiency virus type-1 (HIV-1) in adults. [1] [7] The combination injection is intended for maintenance treatment of adults who have undetectable HIV levels in the blood (viral load less than 50 copies/mL) with their current antiretroviral treatment, and when the virus has not developed resistance to ...
GSK Plc said on Monday that its HIV-focused unit ViiV Healthcare's cabotegravir injected drug and tablets got a positive opinion from the European Medicines Agency for marketing authorisation.
In combination with palbociclib and fulvestrant for the treatment of adults with endocrine-resistant, PIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth-factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer, as detected by an FDA-approved test, following recurrence on or after completing adjuvant ...
WPXI was the first station to offer a 5:30 p.m. newscast in Pittsburgh from 1981 to 1984 (titled 5:30 Live); it was then revived in 1987 with the name Channel 11 News First Edition. It was also the first station to offer a 5 p.m. newscast in the early 1990s, titled Channel 11 News First at 5.
Channel 11 or TV11 may refer to: TV11 (Sweden), a Swedish conditional access entertainment channel; Eleven (Australian TV channel), an Australian free-to-air digital television channel; Canal Once (Mexico), a Mexican educational broadcast television network assigned virtual channel 11 nationwide; XHUNAM-TDT, a television station in Mexico City
A New York doctor has been indicted for allegedly sending abortion pills to a teenager in Louisiana, in what could be the first time a provider has faced criminal charges for mailing the ...
Rilpivirine, sold under the brand name Edurant among others, is a medication, developed by Tibotec, used for the treatment of HIV/AIDS. [6] [7] It is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs such as efavirenz.